AZN spikes 6% after report it denies AstraZeneca-BMS merger talks
Investing.com – AstraZeneca shares surged approximately 6% on Wednesday after a senior source told Reuters there are “no…
AstraZeneca rebounds as report dismisses Bristol Myers Squibb takeover speculation
Astra Zeneca logo on building ©Adobe Stock Images AstraZeneca (LSE:AZN) shares recovered strongly on Wednesday after a Reuters…
Rio Tinto and Glencore release statements regarding possible merger
Save to read list
…